{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:57:30Z","timestamp":1779245850087,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004039","name":"Juntendo Institute of Mental Health","doi-asserted-by":"publisher","award":["2020\u2013003"],"award-info":[{"award-number":["2020\u2013003"]}],"id":[{"id":"10.13039\/501100004039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine: X"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.sleepx.2023.100070","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T12:21:28Z","timestamp":1679919688000},"page":"100070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Safety and real-world efficacy of lemborexant in the treatment of comorbid insomnia"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6949-899X","authenticated-orcid":false,"given":"Narimasa","family":"Katsuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seita","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleepx.2023.100070_bib1","first-page":"79","article-title":"Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population","volume":"10","author":"Doi","year":"2000","journal-title":"J\u00a0Epidemiol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.sleepx.2023.100070_bib2","first-page":"S347","article-title":"Characteristics of insomnia in the United States: results of the 1991 national sleep foundation survey. I","volume":"22","author":"Ancoli\u2013Israel","year":"1999","journal-title":"Sleep"},{"issue":"Suppl.\u00a08","key":"10.1016\/j.sleepx.2023.100070_bib3","first-page":"13","article-title":"Clinical and socioeconomic correlates of insomnia","volume":"65","author":"Walsh","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sleepx.2023.100070_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.smrv.2014.10.005","article-title":"Sleep, sleep disturbance, and fertility in women","volume":"22","author":"Kloss","year":"2015","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleepx.2023.100070_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMcp1412740","article-title":"Clinical practice. Insomnia disorder","volume":"373","author":"Winkelman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/sleep\/23.1.1a","article-title":"An epidemiological study of insomnia among the Japanese general population","volume":"23","author":"Kim","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.sleepx.2023.100070_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00006842-200105000-00013","article-title":"Somatic and psychological complaints and their correlates with insomnia in the Japanese general population","volume":"63","author":"Kim","year":"2001","journal-title":"Psychosom Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11606-018-4390-1","article-title":"Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review","volume":"33","author":"Koffel","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta\u2013analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.sleepx.2023.100070_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamapsychiatry.2022.1150","article-title":"Complex persistent benzodiazepine dependence-when benzodiazepine deprescribing goes awry","volume":"79","author":"Peng","year":"2022","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.sleepx.2023.100070_bib12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.sleepx.2023.100070_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people, version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.sleepx.2023.100070_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein\u2013coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.sleepx.2023.100070_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.sleepx.2023.100070_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.sleepx.2023.100070_bib17","author":"MSD"},{"key":"10.1016\/j.sleepx.2023.100070_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4140\/TCP.n.2017.156","article-title":"A\u00a0review of suvorexant, doxepin, ramelteon, and tasimelteon for the treatment of insomnia in geriatric patients","volume":"32","author":"Edmonds","year":"2017","journal-title":"Consult Pharm"},{"key":"10.1016\/j.sleepx.2023.100070_bib21","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13795","article-title":"Lemborexant for the treatment of insomnia: direct and indirect comparisons with other hypnotics using number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"82","author":"Citrome","year":"2021","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sleepx.2023.100070_bib22","author":"Manual"},{"key":"10.1016\/j.sleepx.2023.100070_bib23","series-title":"ECDEU assessment manual for psychopharmacology","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.sleepx.2023.100070_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211037903","article-title":"Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant","volume":"9","author":"Suzuki","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211039098","article-title":"The effect of lemborexant for insomnia disorder","volume":"9","author":"Suzuki","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/jpm.2021.0509","article-title":"Pilot study of lemborexant for insomnia in cancer patients with delirium","volume":"25","author":"Terada","year":"2022","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14656566.2021.1902987","article-title":"Evaluating lemborexant for the treatment of insomnia","volume":"22","author":"Zammit","year":"2021","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.sleepx.2023.100070_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1358\/dof.2018.043.10.2828699","article-title":"Lemborexant dual orexin receptor antagonist treatment of insomnia","volume":"43","author":"Hoyer","year":"2018","journal-title":"Drugs Future"},{"key":"10.1016\/j.sleepx.2023.100070_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.758","article-title":"Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant","volume":"9","author":"Dayal","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.sleepx.2023.100070_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.734","article-title":"Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant","volume":"9","author":"Landry","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.sleepx.2023.100070_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.sleep.2021.11.005","article-title":"Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study","volume":"89","author":"Furihata","year":"2022","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF03262274","article-title":"Hospitalization as a turning point for sleep medication use in older adults: prospective cohort study","volume":"29","author":"Zisberg","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sleepx.2023.100070_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.12788\/jhm.2739","article-title":"High prevalence of inappropriate benzodiazepine and sedative hypnotic prescriptions among hospitalized older adults","volume":"12","author":"Pek","year":"2017","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.sleepx.2023.100070_bib35","first-page":"259","article-title":"[Treatment of benzodiazepine dependence]","volume":"87","author":"Soyka","year":"2019","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.sleepx.2023.100070_bib36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns: a systematic review of register\u2013based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.sleepx.2023.100070_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029641","article-title":"Factors associated with long\u2013term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan","volume":"9","author":"Takano","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.sleepx.2023.100070_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.117.241422","article-title":"In\u00a0vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist","volume":"362","author":"Beuckmann","year":"2017","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.sleepx.2023.100070_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2020.05.025","article-title":"Lemborexant vs suvorexant for insomnia: a systematic review and network meta-analysis","volume":"128","author":"Kishi","year":"2020","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.sleepx.2023.100070_bib40","first-page":"1296","article-title":"Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis","volume":"27","author":"McElroy","year":"2021","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.sleepx.2023.100070_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/psyg.12858","article-title":"Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders","volume":"22","author":"Okino","year":"2022","journal-title":"Psychogeriatrics"}],"container-title":["Sleep Medicine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590142723000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590142723000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:25:49Z","timestamp":1762914349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590142723000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"alternative-id":["S2590142723000101"],"URL":"https:\/\/doi.org\/10.1016\/j.sleepx.2023.100070","relation":{},"ISSN":["2590-1427"],"issn-type":[{"value":"2590-1427","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and real-world efficacy of lemborexant in the treatment of comorbid insomnia","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleepx.2023.100070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100070"}}